Pfizer Inc. (PFE) 4th Annual Wolfe Research Healthcare Conference (Transcript)Seeking Alpha • 11/18/22
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of dataMarket Watch • 11/18/22
Pfizer says omicron booster is better against new subvariants like BQ.1.1 than old shotsCNBC • 11/18/22
Pfizer and BioNTech say bivalent booster increases neutralizing antibodies against new omicron variantsMarket Watch • 11/18/22
Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron SublineagesGlobeNewsWire • 11/18/22
Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There?Investors Business Daily • 11/17/22
Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The RideInvestors Business Daily • 11/14/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFEPRNewsWire • 11/14/22
Pfizer, BioNTech BA.4/BA.5-adapted booster gets CHMP recommendation for 5-11 year olds in EUMarket Watch • 11/10/22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European UnionGlobeNewsWire • 11/10/22
Pfizer Aims For A First In Respiratory Vaccines, But Is The Stock It A Buy Or A Sell?Investors Business Daily • 11/07/22